SI2588462T1 - Estri metronidazola za zdravljenje rosace-e - Google Patents

Estri metronidazola za zdravljenje rosace-e

Info

Publication number
SI2588462T1
SI2588462T1 SI201130293T SI201130293T SI2588462T1 SI 2588462 T1 SI2588462 T1 SI 2588462T1 SI 201130293 T SI201130293 T SI 201130293T SI 201130293 T SI201130293 T SI 201130293T SI 2588462 T1 SI2588462 T1 SI 2588462T1
Authority
SI
Slovenia
Prior art keywords
treating rosacea
metronidazole esters
metronidazole
esters
rosacea
Prior art date
Application number
SI201130293T
Other languages
English (en)
Inventor
Jean-Guy Boiteau
Jean-Michel Linget
Original Assignee
Galderma Research & Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research & Development filed Critical Galderma Research & Development
Publication of SI2588462T1 publication Critical patent/SI2588462T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SI201130293T 2010-06-29 2011-06-29 Estri metronidazola za zdravljenje rosace-e SI2588462T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1055241A FR2961809B1 (fr) 2010-06-29 2010-06-29 Esters de metronidazole pour traiter la rosacee
EP11729972.7A EP2588462B1 (en) 2010-06-29 2011-06-29 Metronidazole esters for treating rosacea
PCT/EP2011/060923 WO2012001053A1 (en) 2010-06-29 2011-06-29 Metronidazole esters for treating rosacea

Publications (1)

Publication Number Publication Date
SI2588462T1 true SI2588462T1 (sl) 2015-02-27

Family

ID=42790955

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201130293T SI2588462T1 (sl) 2010-06-29 2011-06-29 Estri metronidazola za zdravljenje rosace-e

Country Status (23)

Country Link
US (1) US8802710B2 (sl)
EP (1) EP2588462B1 (sl)
JP (1) JP2013529667A (sl)
KR (1) KR20130088135A (sl)
CN (1) CN102958920A (sl)
AR (1) AR081783A1 (sl)
AU (1) AU2011273498A1 (sl)
BR (1) BR112012032490A2 (sl)
CA (1) CA2801977A1 (sl)
CY (1) CY1115622T1 (sl)
DK (1) DK2588462T3 (sl)
ES (1) ES2518119T3 (sl)
FR (1) FR2961809B1 (sl)
HR (1) HRP20140966T1 (sl)
IN (1) IN2013CN00515A (sl)
MX (1) MX2012014632A (sl)
PL (1) PL2588462T3 (sl)
PT (1) PT2588462E (sl)
RS (1) RS53623B1 (sl)
RU (1) RU2013103693A (sl)
SI (1) SI2588462T1 (sl)
SM (1) SMT201400174B (sl)
WO (1) WO2012001053A1 (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9715942B2 (en) 2015-06-09 2017-07-25 International Business Machines Corporation Built-in self-test (BIST) circuit and associated BIST method for embedded memories

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127274A3 (en) * 1983-03-25 1987-05-20 The Upjohn Company Esters of metronidazole and compositions containing them
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
US8853247B2 (en) * 2007-11-02 2014-10-07 Nektar Therapeutics Oligomer-nitroimidazole anti-infective conjugates

Also Published As

Publication number Publication date
ES2518119T3 (es) 2014-11-04
MX2012014632A (es) 2013-02-07
FR2961809A1 (fr) 2011-12-30
HRP20140966T1 (hr) 2015-01-02
IN2013CN00515A (sl) 2015-07-03
EP2588462B1 (en) 2014-08-13
CA2801977A1 (en) 2012-01-05
PT2588462E (pt) 2014-10-30
BR112012032490A2 (pt) 2016-12-13
CY1115622T1 (el) 2017-01-04
SMT201400174B (it) 2015-01-15
RU2013103693A (ru) 2014-08-10
EP2588462A1 (en) 2013-05-08
JP2013529667A (ja) 2013-07-22
PL2588462T3 (pl) 2015-03-31
RS53623B1 (en) 2015-04-30
DK2588462T3 (da) 2014-11-03
KR20130088135A (ko) 2013-08-07
WO2012001053A1 (en) 2012-01-05
CN102958920A (zh) 2013-03-06
AR081783A1 (es) 2012-10-17
US20130217740A1 (en) 2013-08-22
AU2011273498A1 (en) 2013-01-10
US8802710B2 (en) 2014-08-12
FR2961809B1 (fr) 2012-07-06

Similar Documents

Publication Publication Date Title
HK1243908A1 (zh) 用於前列腺治療的系統
EP2611496A4 (en) Methods of Treatment
PL2780080T3 (pl) Układy do terapii tkanki podskórnej
KG1376C1 (en) Method for keratoconus treatment
EP2621497A4 (en) ASSOCIATION TREATMENT FOR ROSE ACNE
EP2635286A4 (en) METHOD FOR THE TREATMENT OF CANCER
IL225623A0 (en) Psoriasis treatment methods
IL220594A0 (en) Treatment method
EP2688402A4 (en) METHODS FOR THE TREATMENT OR PREVENTION OF UROLOGIC INFLAMMATION
FR2961810B1 (fr) Esters de metronidazole pour traiter la rosacee
EP2536282A4 (en) METHOD FOR THE TREATMENT OF INFECTIONS
GB201019417D0 (en) Processing method
ZA201308117B (en) Avian-based treatment
FR2961811B1 (fr) Esters de metronidazole pour traiter la rosacee
EP2563353A4 (en) COMPOUNDS FOR ANTIFUNGAL TREATMENT
SI2588462T1 (sl) Estri metronidazola za zdravljenje rosace-e
GB201105523D0 (en) Treatment method
AU2012901917A0 (en) Methods for treating cachexia
AU2011903358A0 (en) Treatment
PL393888A1 (pl) Urządzenie do oczyszczania wód opadowych
GB201111247D0 (en) Treatment
GB201109119D0 (en) Treatment
GB201102265D0 (en) Treatment
GB201102277D0 (en) Treatment
GB201102268D0 (en) Treatment